hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 20:16:07 - browse：25225

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Biden report: The neurospychology of memory and aging

explore

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Novo Nordisk touts Wegovy study, but still struggling with supply

Bird flu researchers hone in on Finland’s mink farms

Montana youths win climate lawsuit against state for promoting fossil fuels

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Timeline: How the deadly wildfires took over Maui day by day

hotspot

hotspot

The contrarian view of Viking Therapeutics

explore

Hepatitis C has a cure — but many Americans still lack access to it

Patients, digital health players weigh in on FTC's data privacy plan

Cancer drug shortages should be causing more outrage

Key House Republican on health care plans exit from Congress

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Be careful with at

Dobbs anniversary: the lost opportunity of abortion as health care

BioAge raises $170M for combination therapy with Zepbound

Tori Bowie and the unacceptable rates of Black maternal death

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Wikipedia

Megan Rapinoe shares emotional post following US Women's World Cup exit

Illinois Supreme Court finds assault weapons ban constitutional

What should King Charles tell the public about his cancer?

A disappointing year of Humira biosimilars

Mark Cuban is blaming the wrong people for high drug costs

Gilead might be held responsible for not developing a drug

explore

explore

focus

leisure time